These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11792321)

  • 1. Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter.
    Tahirov TH; Sato K; Ichikawa-Iwata E; Sasaki M; Inoue-Bungo T; Shiina M; Kimura K; Takata S; Fujikawa A; Morii H; Kumasaka T; Yamamoto M; Ishii S; Ogata K
    Cell; 2002 Jan; 108(1):57-70. PubMed ID: 11792321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystals of ternary protein-DNA complexes composed of DNA-binding domains of c-Myb or v-Myb, C/EBPalpha or C/EBPbeta and tom-1A promoter fragment.
    Tahirov TH; Sasaki M; Inoue-Bungo T; Fujikawa A; Sato K; Kumasaka T; Yamamoto M; Ogata K
    Acta Crystallogr D Biol Crystallogr; 2001 Nov; 57(Pt 11):1655-8. PubMed ID: 11679735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter.
    Chayka O; Kintscher J; Braas D; Klempnauer KH
    Mol Cell Biol; 2005 Jan; 25(1):499-511. PubMed ID: 15601869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors.
    Burk O; Mink S; Ringwald M; Klempnauer KH
    EMBO J; 1993 May; 12(5):2027-38. PubMed ID: 8491193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic point mutations in the Myb DNA-binding domain alter the DNA-binding properties of Myb at a physiological target gene.
    Ivanova O; Braas D; Klempnauer KH
    Nucleic Acids Res; 2007; 35(21):7237-47. PubMed ID: 17959653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myb-induced chromatin remodeling at a dual enhancer/promoter element involves non-coding rna transcription and is disrupted by oncogenic mutations of v-myb.
    Wilczek C; Chayka O; Plachetka A; Klempnauer KH
    J Biol Chem; 2009 Dec; 284(51):35314-24. PubMed ID: 19841477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual activation mechanism for Myb-responsive genes in myelomonocytic cells.
    Yamkamon V; Ivanova O; Braas D; Chayka O; Patmasiriwat P; Klempnauer KH
    Blood Cells Mol Dis; 2008; 40(2):219-26. PubMed ID: 17950008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Myb-responsive enhancer of the chicken C/EBPbeta gene.
    Kintscher J; Yamkamon V; Braas D; Klempnauer KH
    Oncogene; 2004 Jul; 23(34):5807-14. PubMed ID: 15195136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic point mutations induce altered conformation, redox sensitivity, and DNA binding in the minimal DNA binding domain of avian myeloblastosis virus v-Myb.
    Brendeford EM; Myrset AH; Hegvold AB; Lundin M; Gabrielsen OS
    J Biol Chem; 1997 Feb; 272(7):4436-43. PubMed ID: 9020167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.
    Mo X; Kowenz-Leutz E; Laumonnier Y; Xu H; Leutz A
    Genes Dev; 2005 Oct; 19(20):2447-57. PubMed ID: 16195416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
    Burk O; Worpenberg S; Haenig B; Klempnauer KH
    EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP.
    Oelgeschläger M; Kowenz-Leutz E; Schreek S; Leutz A; Lüscher B
    Oncogene; 2001 Nov; 20(50):7420-4. PubMed ID: 11704872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of C/EBPbeta and v-Myb is required for synergistic activation of the mim-1 gene.
    Mink S; Kerber U; Klempnauer KH
    Mol Cell Biol; 1996 Apr; 16(4):1316-25. PubMed ID: 8657104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the DNA-binding and transcriptional activation domains of v-Myb cooperate in transformation.
    Dini PW; Eltman JT; Lipsick JS
    J Virol; 1995 Apr; 69(4):2515-24. PubMed ID: 7884901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50.
    Agrawal A; Cha-Molstad H; Samols D; Kushner I
    J Immunol; 2001 Feb; 166(4):2378-84. PubMed ID: 11160296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells.
    Klempnauer KH
    Oncotarget; 2023 Mar; 14():174-177. PubMed ID: 36913305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal-specific C-terminal domain links myeloblastosis oncoprotein (Myb) to an ancient repressor complex.
    Andrejka L; Wen H; Ashton J; Grant M; Iori K; Wang A; Manak JR; Lipsick JS
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17438-43. PubMed ID: 21969598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C/EBPbeta induces chromatin opening at a cell-type-specific enhancer.
    Plachetka A; Chayka O; Wilczek C; Melnik S; Bonifer C; Klempnauer KH
    Mol Cell Biol; 2008 Mar; 28(6):2102-12. PubMed ID: 18195047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types.
    Ness SA; Kowenz-Leutz E; Casini T; Graf T; Leutz A
    Genes Dev; 1993 May; 7(5):749-59. PubMed ID: 7684005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.